XETRA - Delayed Quote EUR

Medigene AG (MDG1.DE)

Compare
1.1140 -0.0300 (-2.62%)
At close: December 16 at 5:35:59 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,446.0000
6,034.0000
31,247.0000
10,463.0000
8,002.0000
Cost of Revenue
1,494.0000
1,643.0000
1,983.0000
1,360.0000
1,292.0000
Gross Profit
5,952.0000
4,391.0000
29,264.0000
9,103.0000
6,710.0000
Operating Expense
21,368.0000
20,540.0000
37,991.0000
19,088.0000
30,043.0000
Operating Income
-15,416.0000
-16,149.0000
-8,727.0000
-9,985.0000
-23,333.0000
Net Non Operating Interest Income Expense
-288.0000
-413.0000
-630.0000
-283.0000
211.0000
Pretax Income
-15,619.0000
-16,592.0000
-9,374.0000
-10,283.0000
-28,403.0000
Tax Provision
314.0000
-415.0000
-1,044.0000
-300.0000
472.0000
Net Income Common Stockholders
-15,933.0000
-16,177.0000
-8,330.0000
-9,983.0000
-28,875.0000
Diluted NI Available to Com Stockholders
-15,933.0000
-16,177.0000
-8,330.0000
-9,983.0000
-28,875.0000
Basic EPS
-0.61
-0.63
-0.32
-0.39
-1.12
Diluted EPS
-0.61
-0.63
-0.32
-0.39
-1.12
Basic Average Shares
26,517.3620
25,865.9770
25,865.9770
25,865.9770
25,865.9770
Diluted Average Shares
26,517.3620
25,865.9770
25,865.9770
25,865.9770
25,865.9770
Total Operating Income as Reported
-15,416.0000
-16,149.0000
-8,727.0000
-9,985.0000
-28,664.0000
Rent Expense Supplemental
--
55.0000
163.0000
104.0000
114.0000
Total Expenses
22,862.0000
22,183.0000
39,974.0000
20,448.0000
31,335.0000
Net Income from Continuing & Discontinued Operation
-15,933.0000
-16,177.0000
-8,330.0000
-9,983.0000
-28,875.0000
Normalized Income
-15,933.0000
-16,177.0000
-8,330.0000
-9,983.0000
-28,875.0000
Interest Income
243.0000
135.0000
29.0000
19.0000
63.0000
Interest Expense
--
548.0000
659.0000
364.0000
428.0000
Net Interest Income
-288.0000
-413.0000
-630.0000
-283.0000
211.0000
EBIT
-15,311.0000
-16,044.0000
-8,715.0000
-9,919.0000
-27,975.0000
EBITDA
-13,816.0000
-14,581.0000
13,137.0000
-6,491.0000
-21,503.0000
Reconciled Cost of Revenue
1,494.0000
1,643.0000
1,983.0000
1,360.0000
1,292.0000
Reconciled Depreciation
1,495.0000
1,463.0000
21,852.0000
3,428.0000
6,472.0000
Net Income from Continuing Operation Net Minority Interest
-15,933.0000
-16,177.0000
-8,330.0000
-9,983.0000
-28,875.0000
Total Unusual Items Excluding Goodwill
--
--
--
--
-2,212.0000
Normalized EBITDA
-13,816.0000
-14,581.0000
13,137.0000
-6,491.0000
-21,503.0000
Tax Rate for Calcs
0.0002
0.0000
0.0001
0.0000
0.0003
12/31/2020 - 6/30/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HPHA.DE Heidelberg Pharma AG
2.4700
+0.82%
 
88Q.DE 4basebio PLC
14.40
+1.41%
 
BIO.DE Biotest Aktiengesellschaft
41.60
0.00%
 
BIO3.DE Biotest Aktiengesellschaft
26.90
+0.75%
 
PSH.DE Sernova Corp.
0.1535
-6.29%
 
T5O0.DE bioXXmed AG
1.3600
+5.02%
 
7V0.DE Darwin AG
27.00
0.00%
 
9VC.DE Atai Life Sciences N.V.
1.3090
+0.65%
 
VSC.F 4SC AG
4.5200
+8.65%
 
VX1.DE Vertex Pharmaceuticals Incorporated
442.80
+0.49%